MoonLake Immunotherapeutics (MLTX) had the highest return between June 1, 2022 and June 30, 2023 by a US stock with a market cap of $2B+, returning 660.1%.
| ASSET | DATE | % RETURN |
|---|---|---|
MoonLake Immunotherapeutics (MLTX) | 6/1/2022 - 6/30/2023 | 660.06% |
Viking Therapeutics (VKTX) | 6/1/2022 - 6/30/2023 | 620.44% |
TG Therapeutics (TGTX) | 6/1/2022 - 6/30/2023 | 472.35% |
Super Micro Computer (SMCI) | 6/1/2022 - 6/30/2023 | 392.78% |
Rhythm Pharmaceuticals (RYTM) | 6/1/2022 - 6/30/2023 | 373.85% |
Nuvalent (NUVL) | 6/1/2022 - 6/30/2023 | 373.82% |
Verona Pharma PLC ADR (VRNA) | 6/1/2022 - 6/30/2023 | 366.67% |
Symbotic (SYM) | 6/1/2022 - 6/30/2023 | 350.16% |
Immunovant (IMVT) | 6/1/2022 - 6/30/2023 | 348.46% |
ELF Beauty (ELF) | 6/1/2022 - 6/30/2023 | 329.27% |
Biohaven Pharmaceutical (BHVN) | 6/1/2022 - 6/30/2023 | 298.67% |
Madrigal Pharmaceuticals (MDGL) | 6/1/2022 - 6/30/2023 | 247.11% |
YPF Sociedad Anonima (YPF) | 6/1/2022 - 6/30/2023 | 230.16% |
Miniso Group Holding (MNSO) | 6/1/2022 - 6/30/2023 | 216.56% |
Protagonist Therapeutics (PTGX) | 6/1/2022 - 6/30/2023 | 212.09% |
New Oriental Education & Technology (EDU) | 6/1/2022 - 6/30/2023 | 201.45% |
Axcelis Technologies (ACLS) | 6/1/2022 - 6/30/2023 | 192.02% |
TransMedics (TMDX) | 6/1/2022 - 6/30/2023 | 187.41% |
Axsome Therapeutics (AXSM) | 6/1/2022 - 6/30/2023 | 184.59% |
Modine Manufacturing (MOD) | 6/1/2022 - 6/30/2023 | 176.55% |
Fluence Energy (FLNC) | 6/1/2022 - 6/30/2023 | 171.01% |
Enel Chile SA ADR (ENIC) | 6/1/2022 - 6/30/2023 | 169.53% |
First Solar (FSLR) | 6/1/2022 - 6/30/2023 | 169.21% |
Arcellx (ACLX) | 6/1/2022 - 6/30/2023 | 164.82% |
Extreme Networks (EXTR) | 6/1/2022 - 6/30/2023 | 160.76% |
